Lupin partners SteinCares to commercialise biosimilar in LATAM

Lupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin America.

May 28, 2025 - 06:00

Lupin partners SteinCares to commercialise biosimilar in LATAM

Lupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin America.

Read the original article

Tags:

Previous Article

What’s been agreed at this year’s World Health Assembly?

FDA to review Otsuka’s sibeprenlimab application for IgAN

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Drugmakers already bet big on mRNA for cancer. Why is Biden going in, too?

STAT+: Drugmakers already bet big on mRNA for cancer. W...

Aug 25, 2023

Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says

Merck CEO refused to testify in Senate because he’s not...

Jan 26, 2024

Immune Thrombocytopenia by NovelMed Therapeutics for Id...

Jul 1, 2023